FDC Limited Recalls Timolol Maleate Eye Drops Due to Defective Containers
FDC Limited recalls Timolol Maleate Ophthalmic Solution USP, 0.5% bottles due to defective containers with yellow spikes lodged in the nozzle.
Recall notice
Defective container; yellow colored spike from cap lodged in the nozzle
Contact the company
What happened, in plain English
FDC Limited is recalling specific lots of Timolol Maleate Ophthalmic Solution USP, 0.5% because the containers are defective. The defect involves a yellow-colored spike from the cap that has become lodged in the nozzle. This recall affects approximately 362,544 bottles distributed nationwide in the United States. Read more at govinfonow.com/recall/32584-fdc-limited-recalls-timolol-maleate-eye-drops-due-to-defective.
Source Summary by GovInfoNow · govinfonow.com/recall/32584-fdc-limited-recalls-timolol-maleate-eye-drops-due-to-defective · Updated October 9, 2026 · FDA enforcement record: FDA #D-0632-2024
Cite this page
“FDC Limited Recalls Timolol Maleate Eye Drops Due to Defective Containers.” GovInfoNow, updated October 9, 2026. https://govinfonow.com/recall/32584-fdc-limited-recalls-timolol-maleate-eye-drops-due-to-defective. Based on FDA recall #D-0632-2024 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0632-2024%22&limit=1).
Why it’s dangerous
The hazard is a physical defect where a yellow spike from the cap is lodged in the nozzle of the bottle. The record does not specify what injuries or risks this defect poses to users.
Who’s affected
Patients who have been prescribed Timolol Maleate Ophthalmic Solution USP, 0.5% from Rising Pharmaceuticals Inc. are affected by this recall.
How to tell if you have this one
Check if you have Timolol Maleate Ophthalmic Solution USP, 0.5% Sterile in 5mL bottles manufactured by FDC Limited and distributed by Rising Pharmaceuticals Inc. Look for NDC 64980-514-05 and one of the following lot numbers with their expiration dates: Lot 083J022 (Exp Sept 25), Lot 083L046 (Exp Nov 25), or Lot 083H009 (Exp July 25).
- Brand
FDC Limited- Category
Drug
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide in the US” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA published this recall 34 days after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0632-2024 (July 18, 2024) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0632-2024 to see it in context.
- Plain-language summary written by qwen3.6:35b-a3b on October 9, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.